Skip to main content

Table 4 Assessment of functional outcome according to the EuroQoL-5D

From: Functional outcome and cost-effectiveness of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a cost-utility analysis

Variable Group A (Active) Group B (Placebo) p-value
Mobility* (mean rank**)    
- Baseline 49.35 43.52 0.052
- 6 weeks 43.28 39.54 0.115
- 9 weeks 39.19 38.76 0.848
- 12 weeks 38.00 37.00 0.646
- 24 weeks 37.54 36.54 0.597
- 52 weeks 36.34 34.50 0.191
Self-Care* (mean rank**)    
- Baseline 51.34 41.44 0.039
- 6 weeks 44.51 37.22 0.111
- 9 weeks 37.24 41.22 0.340
- 12 weeks 37.42 37.58 0.960
- 24 weeks 37.00 37.00 1.00
- 52 weeks 35.29 35.00 0.359
Usual activities* (mean rank**)    
- Baseline 48.6 44.3 0.373
- 6 weeks 42.3 40.6 0.704
- 9 weeks 38.9 39.2 0.945
- 12 weeks 35.9 39.1 0.441
- 24 weeks 38.4 35.5 0.309
- 52 weeks 37.0 33.7 0.215
Pain/discomfort* (mean rank**)    
- Baseline 49.3 43.6 0.250
- 6 weeks 44.3 38.4 0.195
- 9 weeks 39.1 37.8 0.769
- 12 weeks 39.4 35.7 0.379
- 24 weeks 40.7 33.2 0.051
- 52 weeks 37.3 33.4 0.234
Anxiety/depression* (mean rank**)    
- Baseline 47.8 45.1 0.339
- 6 weeks 40.9 42.2 0.625
- 9 weeks 37.8 40.5 0.251
- 12 weeks 35.5 39.5 0.091
- 24 weeks 35.0 39.1 0.038
- 52 weeks 34.4 36.8 0.229
VAS-score† (mean, [95% CI‡])    
- Baseline 72.5 [65.9; 79.0] 78.7 [73.9; 83.4] 0.126
- 6 weeks 78.0 [73.8; 82.3] 82.6 [78.4; 86.8] 0.127
- 9 weeks 82.2 [78.3; 86.1] 82.2 [77.2; 87.3] 0.987
- 12 weeks 84.8 [80.7; 89.0] 82.9 [77.6; 88.3] 0.576
- 24 weeks 88.1 [83.9; 92.2] 88.7 [85.0; 92.4] 0.818
- 52 weeks 87.9 [84.1; 91.8] 90.8 [87.0; 94.7] 0.282
  1. *Mann Whitney U test; p < 0.05.
  2. **Scores are presented as mean rank. The higher the score, the more problems experienced with activities of daily living.
  3. †All variables are denoted as a score between 0-100, with 100 being the best possible outcome.
  4. ‡CI, confidence interval.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us